BACKGROUND: Fabry disease is an X-linked lysosomal storage disorder caused by α-galactosidase enzyme deficiency. We present clinical, biochemical, and histologic findings in children with classical phenotypic presentation of Fabry disease. METHODS: A retrospective analysis was performed using charts from 14 children with confirmed diagnosis. Clinical parameters were evaluated. Globotriaosylsphingosine -lysoGb3- detection in plasma, podocyturia, and kidney biopsy were carried out in all cases. RESULTS: All patients except one demonstrated at least one symptom of Fabry disease. LysoGb3 levels were above the normal range in all patients. Podocyturia was documented in all patients. Kidney biopsy revealed glomerular, interstitial, vascular, and tubular changes on light microscopy in nearly all patients. Electron microscopy showed podocyte inclusions in all patients. CONCLUSIONS: No difference in symptomatology was discernible between boys and girls. Podocyturia was detectable in children serving as a possible early marker of kidney injury. LysoGb3 was elevated in all cases, emphasizing the importance for diagnosis especially in female patients with normal αGal A activity. A possible association between lysoGb3 and symptom severity and histological involvement in kidney biopsy should be assessed in prospective studies with enough statistical power to determine if lysoGb3 can be used to predict nephropathy in children with Fabry disease.
BACKGROUND:Fabry disease is an X-linked lysosomal storage disorder caused by α-galactosidase enzyme deficiency. We present clinical, biochemical, and histologic findings in children with classical phenotypic presentation of Fabry disease. METHODS: A retrospective analysis was performed using charts from 14 children with confirmed diagnosis. Clinical parameters were evaluated. Globotriaosylsphingosine -lysoGb3- detection in plasma, podocyturia, and kidney biopsy were carried out in all cases. RESULTS: All patients except one demonstrated at least one symptom of Fabry disease. LysoGb3 levels were above the normal range in all patients. Podocyturia was documented in all patients. Kidney biopsy revealed glomerular, interstitial, vascular, and tubular changes on light microscopy in nearly all patients. Electron microscopy showed podocyte inclusions in all patients. CONCLUSIONS: No difference in symptomatology was discernible between boys and girls. Podocyturia was detectable in children serving as a possible early marker of kidney injury. LysoGb3 was elevated in all cases, emphasizing the importance for diagnosis especially in female patients with normal αGal A activity. A possible association between lysoGb3 and symptom severity and histological involvement in kidney biopsy should be assessed in prospective studies with enough statistical power to determine if lysoGb3 can be used to predict nephropathy in children with Fabry disease.
Authors: L Echevarria; K Benistan; A Toussaint; O Dubourg; A A Hagege; D Eladari; F Jabbour; C Beldjord; P De Mazancourt; D P Germain Journal: Clin Genet Date: 2015-06-22 Impact factor: 4.438
Authors: Markus Niemann; Arndt Rolfs; Stefan Störk; Bart Bijnens; Frank Breunig; Meinrad Beer; Georg Ertl; Christoph Wanner; Frank Weidemann Journal: Circ Cardiovasc Genet Date: 2014-01-06
Authors: Raphael Schiffmann; Derralynn A Hughes; Gabor E Linthorst; Alberto Ortiz; Einar Svarstad; David G Warnock; Michael L West; Christoph Wanner Journal: Kidney Int Date: 2016-12-18 Impact factor: 10.612
Authors: Brent Fall; C Ronald Scott; Michael Mauer; Stuart Shankland; Jeffrey Pippin; Jonathan A Jefferson; Eric Wallace; David Warnock; Behzad Najafian Journal: PLoS One Date: 2016-12-16 Impact factor: 3.240
Authors: Maria Helena Vaisbich; Luís Gustavo Modelli de Andrade; Cassiano Augusto Braga Silva; Fellype de Carvalho Barreto Journal: J Bras Nefrol Date: 2022 Apr-Jun
Authors: Christoph Wanner; Ulla Feldt-Rasmussen; Ana Jovanovic; Aleš Linhart; Meng Yang; Elvira Ponce; Eva Brand; Dominique P Germain; Derralynn A Hughes; John L Jefferies; Ana Maria Martins; Albina Nowak; Bojan Vujkovac; Frank Weidemann; Michael L West; Alberto Ortiz Journal: ESC Heart Fail Date: 2020-02-26